Covax, an international organization that provides vaccines against COVID-19 to poor countries, said on Wednesday that it needed $ 5.2 billion over three months to fund serum doses for 2022.
In November and December 2021, Kovacs celebrated its billion-dollar dose delivery last weekend after nearly a year of operations and significant encouragement.
“By 2022, by ensuring that doses are used quickly, safely injected, and achieve the nation’s preferences and coverage targets, we can change the way we do business to help prevent the disease,” said Seth Berkeley, president of the Vaccine Coalition. Pillars of Kovacs with WHO, Unicef and CEPI.
“It will help the world reduce the risks of epidemics and uncertainties,” he appealed to donors.
Covax needs $ 3.7 billion to fund a reserve of 600 million doses, which should ensure a balanced distribution and deal with unforeseen events such as booster doses or newer types of vaccines.
It aims to help produce and distribute vaccines so that another billion poor countries are not wasted.
Finally, $ 545 million will be used to cover expenses such as transportation, needles or insurance.
So far, Covax has received $ 192 million from donors.
Seth Berkeley believes the next billion doses will be delivered in four or five months rather than the year taken for the first billion.
Kovacs estimates that it could save one million lives by 2022 and halve the economic cost of the epidemic in some countries, with about 45% of the population in 92 countries benefiting from vaccine donations having access to adequate vaccinations.
But 25 of these countries do not have the infrastructure for an effective vaccination campaign.
WHO President Tetros Adonom Caprais has again condemned the vaccine imbalance, saying that although 10 billion doses of Govt vaccines have been given so far, almost half of the world’s population has not been vaccinated.
He pointed out that it was this inequality that led to the emergence of variants like Omigran and warned that “the next could be worse”.
“By 2022, we can end the acute phase of the epidemic or prolong it. World leaders have a choice, ”he added.